Expert Jeffrey Lancet, MD, discusses the emerging agents in treating acute myeloid leukemia (AML) and challenges that still exist for improving patient outcome.
Jonathan Alicea
Advertisement
Articles by Jonathan Alicea
Advertisement
Latest Updated Articles
New Discoveries in AML Treatments Bring HopePublished: July 19th 2017 | Updated:
Advertisement
Advertisement
